Here are four things to know:
1. The registry is comprised of patients who have received implants of GRAFTYS HBS and GRAFTYS QuickSet.
2. Both the GRAFTYS HBS and GRAFTYS QuickSet are advanced phosphocalcic cements that are highly injectable and resorbable.
3. The goal of establishing the registry is to systematically validate short term and long term clinical results for implantable devices after product launch.
4. GRAFTYS cements can be used in numerous applications, such as bone marrow lesions in the knee.
More articles on devices:
SeaSpine Q3 revenue drops 3%, net loss hits $133M: 5 key notes
Amedica revenue drops 19% in Q3: 5 things to know
VertiFlex, Xtant Medical, Orthofix & more — 23 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
